RECURSION PHARMACEUTICALS, INC. (RXRX)

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Nov 6, 2025 · Gibson Christopher sold 40K shares at $5.21/share ($208.4K); converted 60K shares; gifted 20K shares

Gibson Christopher sold 40K shares at $5.21/share ($208.4K); converted 60K shares; gifted 20K shares

FORM 4

xslF345X05/wk-form4_1762464222.xmlSEC.gov

Graphics and non-inline formats (not embedded below).